Literature DB >> 15505385

Excitotoxicity and bioenergetics in glutaryl-CoA dehydrogenase deficiency.

S Kölker1, D M Koeller, S Sauer, F Hörster, M A Schwab, G F Hoffmann, K Ullrich, J G Okun.   

Abstract

Glutaryl-CoA dehydrogenase deficiency is an inherited organic acid disorder with predominantly neurological presentation. The biochemical hallmark of this disease is an accumulation and enhanced urinary excretion of two key organic acids, glutaric acid and 3-hydroxyglutaric acid. If untreated, acute striatal damage is often precipitated by febrile illnesses during a vulnerable period of brain development in infancy or early childhood, resulting in a dystonic dyskinetic movement disorder. 3-hydroxyglutaric and glutaric acids are structurally similar to glutamate, the main excitatory amino acid of the human brain, and are considered to play an important role in the pathophysiology of this disease. 3-hydroxyglutaric acid induces excitotoxic cell damage specifically via activation of N-methyl-D-aspartate receptors. It has also been suggested that secondary amplification loops potentiate the neurotoxic properties of these organic acids. Probable mechanisms for this effect include cytokine-stimulated NO production, a decrease in energy metabolism, and reduction of cellular creatine phosphate levels. Finally, maturation-dependent changes in the expression of neuronal glutamate receptors may affect the vulnerability of the immature brain to excitotoxic cell damage in this disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505385     DOI: 10.1023/B:BOLI.0000045762.37248.28

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  47 in total

1.  The toxic effect of sodium L-glutamate on the inner layers of the retina.

Authors:  D R LUCAS; J P NEWHOUSE
Journal:  AMA Arch Ophthalmol       Date:  1957-08

2.  Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity.

Authors:  Jürgen G Okun; Friederike Hörster; Lilla M Farkas; Patrik Feyh; Angela Hinz; Sven Sauer; Georg F Hoffmann; Klaus Unsicker; Ertan Mayatepek; Stefan Kölker
Journal:  J Biol Chem       Date:  2002-02-14       Impact factor: 5.157

Review 3.  Striatal degeneration and spongy myelinopathy in glutaric acidemia.

Authors:  D Soffer; N Amir; O N Elpeleg; J M Gomori; R S Shalev; S Gottschalk-Sabag
Journal:  J Neurol Sci       Date:  1992-02       Impact factor: 3.181

Review 4.  Glutaric aciduria type I and kynurenine pathway metabolites: a modified hypothesis.

Authors:  S Varadkar; R Surtees
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

5.  Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I.

Authors:  David M Koeller; Michael Woontner; Linda S Crnic; Bette Kleinschmidt-DeMasters; Janet Stephens; Edgar L Hunt; Stephen I Goodman
Journal:  Hum Mol Genet       Date:  2002-02-15       Impact factor: 6.150

Review 6.  White matter disease in cerebral organic acid disorders: clinical implications and suggested pathomechanisms.

Authors:  S Kölker; E Mayatepek; G F Hoffmann
Journal:  Neuropediatrics       Date:  2002-10       Impact factor: 1.947

7.  Type I glutaric aciduria, part 2: a model of acute striatal necrosis.

Authors:  Kevin A Strauss; D Holmes Morton
Journal:  Am J Med Genet C Semin Med Genet       Date:  2003-08-15       Impact factor: 3.908

8.  3-Hydroxyglutaric acid induces oxidative stress and decreases the antioxidant defenses in cerebral cortex of young rats.

Authors:  Alexandra Latini; Rafael Borba Rosa; Karina Scussiato; Susana Llesuy; Adriane Belló-Klein; Moacir Wajner
Journal:  Brain Res       Date:  2002-11-29       Impact factor: 3.252

9.  3-Hydroxyglutarate excretion is increased in ketotic patients: implications for glutaryl-CoA dehydrogenase deficiency testing.

Authors:  J Pitt; K Carpenter; B Wilcken; A Boneh
Journal:  J Inherit Metab Dis       Date:  2002-05       Impact factor: 4.982

10.  Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS.

Authors:  S J Hewett; C A Csernansky; D W Choi
Journal:  Neuron       Date:  1994-08       Impact factor: 17.173

View more
  18 in total

1.  Geometric restraint drives on- and off-pathway catalysis by the Escherichia coli menaquinol:fumarate reductase.

Authors:  Thomas M Tomasiak; Tara L Archuleta; Juni Andréll; César Luna-Chávez; Tyler A Davis; Maruf Sarwar; Amy J Ham; W Hayes McDonald; Victoria Yankovskaya; Harry A Stern; Jeffrey N Johnston; Elena Maklashina; Gary Cecchini; Tina M Iverson
Journal:  J Biol Chem       Date:  2010-11-23       Impact factor: 5.157

Review 2.  Challenges for basic research in glutaryl-CoA dehydrogenase deficiency.

Authors:  S Kölker; K A Strauss; S I Goodman; G F Hoffmann; J G Okun; D M Koeller
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 3.  Emergency treatment in glutaryl-CoA dehydrogenase deficiency.

Authors:  S Kölker; C R Greenberg; M Lindner; E Müller; E R Naughten; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

4.  Induction of S100B secretion in C6 astroglial cells by the major metabolites accumulating in glutaric acidemia type I.

Authors:  André Quincozes-Santos; Rafael Borba Rosa; Guilhian Leipnitz; Daniela Fraga de Souza; Bianca Seminotti; Moacir Wajner; Carlos Alberto Gonçalves
Journal:  Metab Brain Dis       Date:  2010-05-01       Impact factor: 3.584

5.  (1)H-MRS in glutaric aciduria type 1: impact of biochemical phenotype and age on the cerebral accumulation of neurotoxic metabolites.

Authors:  Inga Harting; Nikolas Boy; Jana Heringer; Angelika Seitz; Martin Bendszus; Petra J W Pouwels; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2015-04-10       Impact factor: 4.982

6.  Toxic Synergism Between Quinolinic Acid and Glutaric Acid in Neuronal Cells Is Mediated by Oxidative Stress: Insights to a New Toxic Model.

Authors:  Paula Pierozan; Ana Laura Colín-González; Helena Biasibetti; Janaina Camacho da Silva; Angela Wyse; Moacir Wajner; Abel Santamaria
Journal:  Mol Neurobiol       Date:  2017-09-21       Impact factor: 5.590

Review 7.  Modulation of glutamatergic and GABAergic neurotransmission in glutaryl-CoA dehydrogenase deficiency.

Authors:  M Wajner; S Kölker; D O Souza; G F Hoffmann; C F de Mello
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 8.  Looking forward--an evidence-based approach to glutaryl-CoA dehydrogenase deficiency.

Authors:  S Kölker; P Burgard; J G Okun; A Schulze-Bergkamen; B Assmann; C R Greenberg; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

9.  Outcome of three cases of untreated maternal glutaric aciduria type I.

Authors:  Paula Garcia; Esmeralda Martins; Luísa Diogo; Hugo Rocha; Ana Marcão; Eurico Gaspar; Margarida Almeida; Catarina Vaz; Isabel Soares; Clara Barbot; Laura Vilarinho
Journal:  Eur J Pediatr       Date:  2007-07-28       Impact factor: 3.183

10.  Age and brain structural related effects of glutaric and 3-hydroxyglutaric acids on glutamate binding to plasma membranes during rat brain development.

Authors:  Karina B Dalcin; Rafael B Rosa; Anna L Schmidt; Juliana S Winter; Guilhian Leipnitz; Carlos S Dutra-Filho; Clóvis M D Wannmacher; Lisiane O Porciúncula; Diogo O Souza; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2007-09-05       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.